Allergan, PLC. has recalled approximately 133,716 cartons of Ozurdex (dexamethasone intravitreal implant) 0.7 mg, a prescription medication used for eye conditions. The recall was initiated because a silicone particle was discovered within the implant during manufacturing, which is a violation of Good Manufacturing Practices. Consumers should be aware that these affected units were distributed nationwide to various accounts, including government and VA facilities.
The presence of a foreign silicone particle inside the eye implant could lead to unintended inflammation or other complications within the eye where the medication is administered. While the risk is categorized as medium, any foreign material introduced during an intravitreal injection poses a potential safety concern for patients.
Healthcare provider consultation and product return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.